Yo Kunii Selected Research

Potassium Iodide (Pima)

6/2020	Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease.
1/2020	Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy.
1/2019	Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy.
10/2015	Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yo Kunii Research Topics

Disease

15	Graves Disease (Basedow Disease) 06/2020 - 01/2011
6	Hyperthyroidism 01/2020 - 12/2012
4	Thyrotoxicosis 11/2021 - 07/2012
3	Thyroid Diseases (Thyroid Disease) 01/2018 - 01/2011
3	Graves Ophthalmopathy 01/2018 - 07/2015
3	Agranulocytosis (Granulocytopenia) 05/2014 - 01/2012
2	Vasculitis (Vasculitides) 01/2014 - 08/2009
1	Myocardial Infarction 11/2021
1	Disease Progression 01/2020
1	Chemical and Drug Induced Liver Injury 10/2019
1	Constipation 01/2018
1	Neutropenia 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Fetal Diseases (Embryopathy) 10/2015
1	Chronic Thyroiditis 01/2015
1	Thyroid Nodule (Nodule, Thyroid) 01/2015
1	Lymphoma (Lymphomas) 06/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2014
1	Thyroid Neoplasms (Thyroid Cancer) 01/2014
1	Atrial Fibrillation 01/2013
1	Tachycardia (Tachyarrhythmias) 01/2013
1	Pancytopenia 01/2012
1	Infections 01/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2011
1	Inflammation (Inflammations) 01/2011
1	Thyroiditis 01/2011
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 08/2009

Drug/Important Bio-Agent (IBA)

9	Antithyroid Agents (Antithyroid Drugs)IBA 10/2019 - 08/2009
6	Methimazole (Thiamazole)FDA LinkGeneric 01/2020 - 08/2009
4	Potassium Iodide (Pima)FDA Link 06/2020 - 10/2015
3	Thyroid HormonesIBA 01/2020 - 01/2013
3	IodineIBA 10/2015 - 01/2014
3	Propylthiouracil FDA Link 05/2014 - 08/2009
2	Long-Acting Thyroid Stimulator (LATS)IBA 01/2019 - 01/2011
2	Troleandomycin (TAO)FDA Link 01/2018 - 01/2011
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2014 - 08/2009
2	AntibodiesIBA 01/2011 - 01/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021
1	TroponinIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	IodidesIBA 01/2020
1	thyrotropin-binding inhibitory immunoglobulinIBA 01/2016
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2015
1	Rituximab (Mabthera)FDA Link 06/2014
1	Bepridil (Vascor)FDA Link 12/2012
1	SteroidsIBA 01/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2012
1	GlucocorticoidsIBA 01/2011
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2011
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2011
1	Pharmaceutical PreparationsIBA 08/2009
1	Peroxidase (Myeloperoxidase)IBA 08/2009

Therapy/Procedure

8	Therapeutics 01/2019 - 01/2011
3	Drug Therapy (Chemotherapy) 01/2018 - 04/2011
1	Thyroidectomy 04/2014
1	Electric Countershock (Cardioversion) 01/2013
1	Radiotherapy 04/2011
1	Combined Modality Therapy 04/2011